Author details

Cristina de Andrade Monteiro\* and Julliana Ribeiro Alves dos Santos Universidade Ceuma, Brazil

\*Address all correspondence to: cristina.monteiro@ceuma.br

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

[1] Vallabhaneni S, Chiller TM. Fungal infections and new biologic therapies. Current Rheumatology Reports. 2016; 18:29. DOI: 10.1007/s11926-016-0572-1

DOI: http://dx.doi.org/10.5772/intechopen.87302

Phytochemicals and Their Antifungal Potential against Pathogenic Yeasts

[9] Molina-Leyva A, Ruiz-Carrascosa JC, Leyva-Garcia A, Husein-Elahmed H. Cutaneous Cryptococcus laurentii

infection in an immunocompetent child. International Journal of Infectious Diseases. 2013;17:e1232-e1233. DOI:

[10] Franco C, Tomei F, Assalone P, Traficante D, Di Pilla G, Pepe C, et al. Cryptococcus laurentii diarrhea in a neoplastic patient. Case Reports in Oncological Medicine. 2015:216458, 2 pages. DOI: 10.1155/2015/216458

[11] Smith N, Sehring M, Chambers J, Patel P. Perspectives on non-neoformans cryptococcal opportunistic infections. Journal of Community Hospital Internal Medicine Perspectives. 2017;7(4): 214-217. DOI: 10.1080/20009666.2017.

[12] Springer DJ, Chaturvedi V. Projecting global occurrence of

10.3201/eid1601.090369

Cryptococcus gattii. Emerging Infectious Diseases. 2010;16(10):14-20. DOI:

[13] Negroni R. Cryptococcosis. Clinics in Dermatology. 2012;30:599-609. DOI: 10.1016/j.clindermatol.2012.01.005

[14] Cogliati M. Global molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii: An atlas of the molecular types. Scientifica (Cairo). 2013;2013:675213. DOI: 10.1155/2013/

[15] Chayakulkeeree M, Perfect JR. Cryptococcosis. Infectious Disease Clinics of North America. 2006;20(3):

[16] Chaturvedi V, Chaturvedi S. Cryptococcus gattii: A resurgent fungal pathogen. Trends in Microbiology. 2011;

19(11):564-571. DOI: 10.1016/j.

10.1016/j.ijid.2013.04.017

1350087

675213

507-544, v-vi

tim.2011.07.010

[2] Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: Human fungal infections. Science Translational

Medicine. 2012;4:165rv13. DOI: 10.1126/

[3] López-Martínez R. Candidosis, a new challenge. Clinics in Dermatology. 2010; 28:178-184. DOI: 10.1016/j.clindermatol.

[4] Gow NAR, Hube B. Importance of the Candida albicans cell wall during commensalism and infection. Current Opinion in Microbiology. 2012;15: 406-412. DOI: 10.1016/j.mib.2012.

[5] Barchiesi F, Orsetti E, Osimani P, Catassi C, Santelli F, Manso E. Factors related to outcome of bloodstream infections due to Candida parapsilosis complex. BMC Infectious Diseases. 2016;16:387. DOI: 10.1186/s12879-016-

Cryptococcosis in the era of AIDS—100 years after the discovery of Cryptococcus neoformans. Clinical Microbiology Reviews. 1995;8(4):515-548

[7] Bovers M, Hagen F, Boekhout T. Diversity of the Cryptococcus

neoformans-Cryptococcus gattii species complex. Revista Iberoamericana de

[8] Hurtado JCC, Fernandes P, Navarro F, Lovane M, Casas L, Quintó I, et al. Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: An autopsy study. Scientific Reports. 2019;9:7493. DOI: 10.1038/

[6] Mitchell TG, Perfect JR.

Micologia. 2008;25(1):4-12

s41598-019-43941-w

249

scitranslmed.3004404

2009.12.014

04.005

1704-y

Phytochemicals and Their Antifungal Potential against Pathogenic Yeasts DOI: http://dx.doi.org/10.5772/intechopen.87302
